Neurologist Dr. David Perlmutter asserts that billions spent on Alzheimer's drug development have largely focused on the wrong targets, suggesting that the key to prevention and treatment lies in managing the brain's specialized immune cells, microglia. Instead of solely targeting beta-amyloid plaques, Perlmutter emphasizes that the excessive activation of microglia, shifting them from a protective M2 state to a damaging M1 state, is a more significant factor in neurodegeneration. This shift can be triggered by aging, infection, poor diet, and lifestyle factors that promote gut inflammation, leading to attacks on brain cells and synapses.
Perlmutter highlights that lifestyle changes, including regular exercise and a diet rich in fiber and low in ultra-processed foods, can positively influence microglia. Additionally, he points to existing medications and common dietary supplements as potential tools for optimizing microglial function. While not advocating for self-medication or replacing a healthy diet, Perlmutter, with over 40 years of experience treating neurodegenerative diseases, expresses encouragement about the potential of these interventions.
Medications Targeting Microglia
Certain existing medications are showing promise. Metformin, primarily used for type 2 diabetes, is thought to support microglia by enhancing mitochondrial function and improving insulin sensitivity, thereby reducing overactivation. Clinical trials, including the upcoming TAME (Targeting Aging with Metformin) trial, are exploring its potential as an anti-aging drug with implications for cognitive decline.
GLP-1 agonists, such as Ozempic, are also noted for their ability to alter microglia function positively. Studies indicate these drugs can reduce neuroinflammation and increase levels of brain-derived neurotrophic factor (BDNF), a protein vital for neuron health. Research analyzing medical records of diabetic patients treated with Ozempic showed a significantly lower risk of Alzheimer's diagnosis. A clinical trial involving liraglutide demonstrated slower cognitive decline and reduced brain cell loss in Alzheimer's patients.
Other medications like minocycline, an antibiotic with anti-inflammatory properties, and dimethyl fumarate, used for multiple sclerosis, are also mentioned for their ability to inhibit microglial activation and reduce neuroinflammation.
Nutritional Supplements for Brain Health
Perlmutter suggests that certain supplements can complement a healthy diet and support microglial health. Omega-3 fatty acids, particularly DHA, are crucial structural components of brain cells and possess anti-inflammatory properties that can reduce neuroinflammation and boost BDNF levels. The recommended daily intake is 1,000 to 2,000 mg of DHA, with sources like cod liver oil, algae-based supplements, and fatty fish being beneficial.
Creatine is noted for its role in shuttling energy to brain synapses and enhancing mitochondrial function, which aids microglia. Preliminary studies suggest improvements in cognitive abilities for Alzheimer's patients taking creatine supplements. However, individuals with kidney disease or taking nephrotoxic drugs should consult a doctor.
Magnesium, especially magnesium threonate, supports hundreds of biochemical reactions, including nerve function and stress reduction, indirectly benefiting microglia by enhancing mitochondrial function. Leafy greens, nuts, and whole grains are dietary sources, with a recommended daily dosage of 200 to 400 mg.
Probiotics are recommended due to the established link between gut microbiome health and brain function, including microglial influence. A high-quality probiotic with a diverse range of strains and a high colony-forming unit count is advised.
MitoQ10, a synthetic form of coenzyme Q10, is designed to protect mitochondria and may reduce neuron death in Alzheimer's. Sprouted Himalayan tartary buckwheat is highlighted as a superfood rich in polyphenols, which act as antioxidants and support mitochondria. However, potential interactions with certain medications should be considered.
Perlmutter advises consulting a healthcare professional before starting any new supplement regimen, especially for individuals with underlying health conditions or those taking other medications.